General Information of DME (ID: DME0005)
DME Name Cytochrome P450 2A6 (CYP2A6), Homo sapiens
Synonyms Cytochrome P450 family 2 subfamily A member 6; Coumarin 7-hydroxylase; Cytochrome P450 IIA3; Cytochrome P450(I); CYP2A3; CYP2A6; CYPIIA6
Gene Name CYP2A6
UniProt ID
CP2A6_HUMAN
Gene ID
1548
EC Number    EC: 1.14.14.1     (Click to Show/Hide the Complete EC Tree)
Oxidoreductase
Oxygen paired donor oxidoreductase
Flavin/flavoprotein donor oxidoreductase
EC: 1.14.14.1
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
(loading-time for this interactome depdends on the speed of web connection)
       Interactions between Microbiome and DME (MICBIO)                       
Jump to Detailed Interactome Data                      
       Interactions between Xenobiotics and DME (XEOTIC)                      
Jump to Detailed Interactome Data                      
       Interactions between Host Protein and DME (HOSPPI)                     
Jump to Detailed Interactome Data                      
      Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME
Sequence
MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMK
ISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSN
GERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSN
VISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQL
LQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFI
GGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQ
RFGDVIPMSLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEK
GQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGF
ATIPRNYTMSFLPR
Structure
2FDU ; 2FDV ; 2FDW ; 2FDY ; 3EBS ; 3T3Q ; 3T3R ; 4EJJ ; 4RUI
Pathway Caffeine metabolism (hsa00232 )
Chemical carcinogenesis (hsa05204 )
Drug metabolism - cytochrome P450 (hsa00982 )
Drug metabolism - other enzymes (hsa00983 )
Metabolic pathways (hsa01100 )
Metabolism of xenobiotics by cytochrome P450 (hsa00980 )
Retinol metabolism (hsa00830 )
Function This enzyme exhibits a high coumarin 7-hydroxylase activity. It can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. It is also competent in the metabolic activation of aflatoxin B1.
Full List of Drug(s) Metabolized by This DME
      Drugs Approved by FDA Click to Show/Hide the Full List of Drugs:        55 Drugs
Thalidomide
Drug Info Approved Breast cancer ICD11: 2C60 [1]
Tamoxifen citrate
Drug Info Approved Breast cancer ICD11: 2C60 [2]
Nicotine
Drug Info Approved Nicotine dependence ICD11: 6C4A [3]
Apremilast
Drug Info Approved Psoriasis vulgaris ICD11: EA90 [4]
Dronabinol
Drug Info Approved Anorexia nervosa ICD11: 6B80 [5]
Montelukast sodium
Drug Info Approved Asthma ICD11: CA23 [6]
Progesterone
Drug Info Approved Premature labour ICD11: JB00 [7]
Lidocaine
Drug Info Approved Anaesthesia ICD11: 8E22 [7]
Metronidazole
Drug Info Approved Amebiasis ICD11: 1A36 [8]
Ifosfamide
Drug Info Approved Lung cancer ICD11: 2C25 [9]
Tretinoin
Drug Info Approved Acne vulgaris ICD11: ED80 [7]
Valproic acid
Drug Info Approved Epilepsy ICD11: 8A60 [10]
Halothane
Drug Info Approved Anaesthesia ICD11: 8E22 [11]
Cisapride
Drug Info Approved Gastro-oesophageal reflux disease ICD11: DA22 [12]
Lorcaserin
Drug Info Approved Obesity ICD11: 5B81 [13]
Nevirapine
Drug Info Approved Human immunodeficiency virus infection ICD11: 1C60 [6]
Norethindrone acetate
Drug Info Approved Menorrhagia ICD11: GA20 [14]
Belinostat
Drug Info Approved Anaplastic large cell lymphoma ICD11: 2A90 [15]
Cenobamate
Drug Info Approved Focal seizure ICD11: 8A68 [16]
Cyclophosphamide
Drug Info Approved Multiple myeloma ICD11: 2A83 [17]
Dexmedetomidine hydrochloride
Drug Info Approved Tension headache ICD11: 8A81 [18]
Efavirenz
Drug Info Approved Human immunodeficiency virus infection ICD11: 1C60 [19]
Flurazepam
Drug Info Approved Insomnia ICD11: 7A00 [20]
Azelastine
Drug Info Approved Allergic rhinitis ICD11: CA08 [21]
Clozapine
Drug Info Approved Schizophrenia ICD11: 6A20 [22]
Methimazole
Drug Info Approved Thyrotoxicosis ICD11: 5A02 [23], [24]
Methimazole
Drug Info Approved Thyrotoxicosis ICD11: 5A02 [24]
Propofol
Drug Info Approved Anaesthesia ICD11: 8E22 [25]
Vortioxetine hydrobromide
Drug Info Approved Depression ICD11: 6A71 [26]
Acetaminophen
Drug Info Approved Anaesthesia ICD11: 8E22 [27]
Dapagliflozin
Drug Info Approved Diabetes mellitus ICD11: 5A10 [28]
Deferiprone
Drug Info Approved Thalassaemia ICD11: 3A50 [29]
Fluorouracilo
Drug Info Approved Stomach cancer ICD11: 2B72 [30]
Lenvatinib
Drug Info Approved Thyroid cancer ICD11: 2D10 [31]
Levomethadyl acetate hydrochloride
Drug Info Approved Opiate dependence ICD11: 6C43 [32]
Timolol maleate
Drug Info Approved Essential hypertension ICD11: BA00 [33]
Zidovudine
Drug Info Approved Human immunodeficiency virus infection ICD11: 1C60 [7]
Arformoterol
Drug Info Approved Chronic obstructive pulmonary disease ICD11: CA22 [34]
Azilsartan
Drug Info Approved Hypertension ICD11: BA00-BA04 [35], [36]
Clofibrate
Drug Info Approved Hypertriglyceridaemia ICD11: 5C80 [37]
Moxidectin
Drug Info Approved Onchocerciasis ICD11: 1F6A [38]
Selegiline
Drug Info Approved Major depressive disorder ICD11: 6A70-6A7Z [39]
Selegiline hydrochloride
Drug Info Approved Parkinsonism ICD11: 8A00 [40]
Artesunate
Drug Info Approved Malaria ICD11: 1F40-1F45 [41]
Chlorzoxazone
Drug Info Approved Anaesthesia ICD11: 8E22 [42]
Dorzolamide hydrochloride
Drug Info Approved Glaucoma ICD11: 9C61 [43], [44]
Letrozole
Drug Info Approved Breast cancer ICD11: 2C60 [45]
Meloxicam
Drug Info Approved Osteoarthritis ICD11: FA00 [46]
Menthol
Drug Info Approved Throat irritation ICD11: CA0Z [47]
Pilocarpine
Drug Info Approved Glaucoma ICD11: 9C61 [48]
Sevoflurane
Drug Info Approved Anaesthesia ICD11: 8E22 [49]
FADROZOLE
Drug Info Approved Breast cancer ICD11: 2C60-2C6Y [50]
FADROZOLE
Drug Info Approved Breast cancer ICD11: 2C60-2C6Y [50], [51]
Methoxsalen
Drug Info Approved Psoriasis vulgaris ICD11: EA90 [52]
Methoxyflurane
Drug Info Approved Anaesthesia ICD11: 8E22 [49]
      Drugs in Phase 4 Clinical Trial Click to Show/Hide the Full List of Drugs:          9 Drugs
Artemisinin
Drug Info Phase 4 Malaria ICD11: 1F40 [52]
Tegafur-uracil
Drug Info Phase 4 Colon cancer ICD11: 2B90 [53]
Cinnarizine
Drug Info Phase 4 Haemorrhagic stroke ICD11: 8B20 [6]
Medifoxamine
Drug Info Phase 4 Depression ICD11: 6A71 [7]
Phenacetin
Drug Info Phase 4 Anaesthesia ICD11: 8E22 [54]
Flunarizine
Drug Info Phase 4 Schizophrenia ICD11: 6A20 [37]
Flunitrazepam
Drug Info Phase 4 Insomnia ICD11: 7A00 [55]
Perazine
Drug Info Phase 4 Cerebrovascular dementia ICD11: 6D81 [56]
Tegafur
Drug Info Phase 4 Colon cancer ICD11: 2B90 [57]
      Drugs in Phase 3 Clinical Trial Click to Show/Hide the Full List of Drugs:          8 Drugs
Selumetinib
Drug Info Phase 3 Neurofibromatosis ICD11: LD2D [58]
BMS-650032
Drug Info Phase 3 Viral hepatitis ICD11: 1E51 [59]
Y-100032
Drug Info Phase 3 Multiple myeloma ICD11: 2A83 [60]
HSDB-3466
Drug Info Phase 3 Psoriasis vulgaris ICD11: EA90 [61]
LY-450139
Drug Info Phase 3 Alzheimer disease ICD11: 8A20 [62]
BRN-1907611
Drug Info Phase 3 Inflammatory bowel disease ICD11: DD72 [63]
WY-1485
Drug Info Phase 3 Haemorrhagic stroke ICD11: 8B20 [7]
Montelukast
Drug Info Phase 3 Asthma ICD11: CA23 [6]
      Drugs in Phase 2 Clinical Trial Click to Show/Hide the Full List of Drugs:          4 Drugs
EMD-128130
Drug Info Phase 2/3 Rett syndrome ICD11: LD90 [64]
Roxatidine
Drug Info Phase 2 Gastro-oesophageal reflux disease ICD11: DA22 [65]
Z-4828
Drug Info Phase 2 Histiocytic sarcoma ICD11: 2B31 [66]
LJPC-0118
Drug Info Phase 2 Malaria ICD11: 1F40 [67]
      Drugs in Phase 1 Clinical Trial Click to Show/Hide the Full List of Drugs:          2 Drugs
Alvespimycin hydrochloride
Drug Info Phase 1 Ovarian cancer ICD11: 2C73 [68]
OSI-930
Drug Info Phase 1 Solid tumour/cancer ICD11: 2A00-2F9Z [69]
      Discontinued/withdrawn Drugs Click to Show/Hide the Full List of Drugs:          1 Drugs
SM-10661
Drug Info Discontinued in Phase 2 Sepsis ICD11: 1G40-1G41 [70]
      Preclinical/investigative Agents Click to Show/Hide the Full List of Drugs:        10 Drugs
Coumarin
Drug Info Investigative Discovery agent ICD: N.A. [71], [72]
Flavone
Drug Info Investigative Colon cancer ICD11: 2B90 [73]
Flavone
Drug Info Investigative Colon cancer ICD11: 2B90 [74]
Cotinine
Drug Info Investigative Nicotine dependence ICD11: 6C4A [75]
Antipyrine
Drug Info Investigative Discovery agent ICD: N.A. [76]
Chloroxylenol
Drug Info Investigative Pseudomonas infection ICD11: 1G40 [7]
Fenthion
Drug Info Investigative Discovery agent ICD: N.A. [77]
Fenthion sulfoxide
Drug Info Investigative Discovery agent ICD: N.A. [77]
Levoverbenone
Drug Info Investigative Pulmonary tuberculosis ICD11: 1B10 [78]
Nicotinyl alcohol
Drug Info Investigative Hypertriglyceridaemia ICD11: 5C80 [79]
      Experimental Enzyme Kinetic Data of Drugs Click to Show/Hide the Full List of Drugs:          2 Drugs
Fenthion
Drug Info Investigative Discovery agent Km = 0.0016 microM [77]
Fenthion sulfoxide
Drug Info Investigative Discovery agent Km = 0.018 microM [77]
Full List of Metabolic Reactions (MR) Catalyzed by This DME
MR ID Reactant Product MR Type Source Drug REF
MR000050 Acetaminophen NAPQI Oxidation - Oxidation Acetaminophen [80], [81]
MR000276 Apremilast O-desmethyl Apremilast Oxidation - O-Demethylation Apremilast [82]
MR006031 Belinostat Belinostat Amide Unclear - Unclear Belinostat [15]
MR006033 Belinostat Belinostat Acid Unclear - Unclear Belinostat [15]
MR000454 BRN-1907611 5-Exo-hydroxycamphor Oxidation - Hydroxylation BRN-1907611 [83], [84]
MR006255 Chloroxylenol Unclear Unclear - Unclear Chloroxylenol [7]
MR013303 Cinnarizine Cinnarizine metabolite M1 Unclear - Unclear Cinnarizine [6]
MR013306 Cinnarizine Cinnamaldehyde Oxidation - N-dealkylation Cinnarizine [85]
MR013307 Cinnarizine 1-Cinnamylpiperazine Oxidation - N-dealkylation; hydrolysis Cinnarizine [85]
MR005300 Cotinine Trans-3'-hydroxycotinine Oxidation - Hydrolyzationn Cotinine [75]
MR005304 Cotinine Norcotinine Oxidation - N-demethylation Cotinine [75]
MR005309 Coumarin 7-Hydroxycoumarin Oxidation - Hydroxy Aromaticlation Coumarin [71], [72]
MR007425 CT-1501R Lisofylline 4,5-diol Unclear - Unclear CT-1501R [86]
MR002839 Dapagliflozin Dapagliflozin BMS-511926 Oxidation - O-Deethylation Dapagliflozin [87]
MR002840 Dapagliflozin Dapagliflozin BMS-639432 Oxidation - Hydroxylation Dapagliflozin [87]
MR002939 Deferiprone Deferiprone metabolite M1 Unclear - Unclear Deferiprone [29]
MR002935 Deferiprone metabolite M1 Deferiprone metabolite M4 Unclear - Unclear Deferiprone [29]
MR000803 Dexmedetomidine hydrochloride MPV-1305 Oxidation - Hydroxylation Dexmedetomidine hydrochloride [88]
MR010554 Divalproex sodium 4-ene-VPA Unclear - Unclear Divalproex sodium [6]
MR006651 Dorzolamide hydrochloride N-desethyldorzolamide Oxidation - N-deethylation Dorzolamide hydrochloride [43], [44]
MR006045 EMD-128130 Sarizotan metabolite M364A Oxidation - Hydrolyzationn EMD-128130 [64]
MR006309 Flavone 6OHF Unclear - Unclear Flavone [74]
MR006310 Flavone OHFM7 Unclear - Unclear Flavone [74]
MR006311 Flavone OHFM12 Unclear - Unclear Flavone [74]
MR006312 Flavone OHFM11 Unclear - Unclear Flavone [74]
MR006313 Flavone OHFM9 Unclear - Unclear Flavone [74]
MR006314 Flavone OHFM6 Unclear - Unclear Flavone [74]
MR013905 Flunarizine Flunarizine M1 Oxidation - N-desalkylation Flunarizine [6]
MR013907 Flunarizine Flunarizine M3 Oxidation - N-desalkylation Flunarizine [6]
MR002944 Formoterol O-demethylated formoterol Oxidation - O-demethylation Formoterol [89], [90]
MR005083 Halothane 2-chloro-1,1-difluoroethene Reduction - Dehalogenation Halothane [7], [91]
MR005084 Halothane 1-chloro-2,2,2-trifluoroethanide Reduction - Dehalogenation Halothane [7], [91]
MR005085 Halothane Trifluoroacetyl chloride Reduction - Dehalogenation Halothane [91]
MR005086 Halothane Chlorotrifluoroethane Reduction - Dehalogenation Halothane [91]
MR005083 Halothane 2-chloro-1,1-difluoroethene Reduction - Dehalogenation Halothane [91]
MR004650 Ifosfamide 4-Hydroxyifosfamide Oxidation - 4-hydroxylation Ifosfamide [92]
MR010933 Lenvatinib O-demethyl Lenvatinib Unclear - Unclear Lenvatinib [31]
MR001447 Letrozole Letrozole ketone analog metabolite Unclear - Unclear Letrozole [93]
MR001445 Letrozole ketone analog metabolite 4,4'-methanol-bisbenzonitrile Unclear - Unclear Letrozole [93]
MR001555 Lidocaine . Unclear - Unclear Lidocaine [7]
MR006906 Lorcaserin N-hydroxylorcaserin Oxidation - Hydrolyzationn Lorcaserin [13]
MR003762 LY-450139 LY-2484595 Metabolite M3 Oxidation - Benzylic hydroxylation LY-450139 [62]
MR002857 Meloxicam 5-hydroxymethyl meloxicam Oxidation - Hydroxylation Meloxicam [94], [46]
MR010871 Menthol Menthane-3,4-diol Unclear - Unclear Menthol [47]
MR013817 Methimazole N-methylthiourea Unclear - Unclear Methimazole [23], [24]
MR004727 Metronidazole 2-hydroxymetronidazole Oxidation - Hydrolyzationn Metronidazole [8], [95], [96], [97]
MR004799 Montelukast sodium Montelukast sulfoxide Oxidation - S-oxidation Montelukast sodium [6], [98]
MR004799 Montelukast sodium Montelukast metabolite M2a/b Unclear - Unclear Montelukast sodium [6]
MR004809 Moxidectin Monohydroxy metabolite of moxidectin at C29 Oxidation - Hydrolyzationn Moxidectin [38]
MR004810 Moxidectin Monohydroxy metabolite of moxidectin at the C14 Oxidation - Hydrolyzationn Moxidectin [38]
MR001717 NCI-C50000 p-Menthane-3,-8-diol Oxidation - Hydroxylation NCI-C50000 [99]
MR002966 Cotinine 3'-hydroxycotinine Oxidation - 3'-Hydroxylation Nicotine [100]
MR002960 Nicotine (S)-Nicotine delta-1',5'-iminium ion Oxidation - Heteroring Dehydrogenation Nicotine [100]
MR002953 Nicotine Nicotine imine Unclear - Unclear Nicotine [101]
MR002961 Nicotine 2'-hydroxynicotine Oxidation - Hydroxylation Nicotine [91]
MR001764 Nitrofurantoin Nitrofurantoin metabolite M10 Oxidation - Oxidation Nitrofurantoin [102]
MR001765 Nitrofurantoin Nitrofurantoin metabolite 8(M1/M2) Oxidation - Oxidation Nitrofurantoin [102]
MR001766 Nitrofurantoin Nitrofurantoin metabolite 9(M1/M2) Oxidation - Oxidation Nitrofurantoin [102]
MR001762 Nitrofurantoin metabolite M10 Nitrofurantoin metabolite 8(M1/M2) Oxidation - Oxidation Nitrofurantoin [102]
MR001763 Nitrofurantoin metabolite M10 Nitrofurantoin metabolite 9(M1/M2) Oxidation - Oxidation Nitrofurantoin [102]
MR002014 Acetaminophen NAPQI Oxidation - Oxidation Phenacetin [103]
MR002878 Pilocarpine 3-hydroxypilocarpine Oxidation - Hydroxylation Pilocarpine [48]
MR009603 Roxatidine M4 Roxatidine M5 Unclear - Unclear Roxatidine [65]
MR008392 SM-10661 S-Oxide Unclear - Unclear SM-10661 [104], [105], [70]
MR008432 STX 64 STX 64 metabolite M7 Oxidation - Hydroxylation STX 64 [106]
MR005270 5'-hydroxytegafur Fluorouracil Other reaction - Degradation Tegafur [7], [30]
MR005269 Tegafur 5'-hydroxytegafur Oxidation - 5-hydroxylation Tegafur [7], [30]
MR005271 Tegafur-uracil 5-hydroxytegafur Oxidation - Hydrolyzationn Tegafur-uracil [107]
MR005279 Tegafur-uracil 3-hydroxytegafur Oxidation - Hydrolyzationn Tegafur-uracil [107]
MR005280 Tegafur-uracil 4-hydroxytegafur Oxidation - Hydrolyzationn Tegafur-uracil [107]
MR005281 Tegafur-uracil Dihydrotegafur Oxidation - Hydrolyzationn Tegafur-uracil [7], [30], [108]
MR004995 M1 metabolite, timolol Timolol maleate Metabolite M4 Unclear - Unclear Timolol maleate [33]
MR004996 M1 metabolite, timolol Timolol maleate Metabolite M3 Unclear - Unclear Timolol maleate [33]
MR004997 Timolol maleate Timolol maleate Metabolite M2 Unclear - Unclear Timolol maleate [33]
MR009627 4-Hydroxyretinoic acid 4-Oxoretinoic acid Oxidation - Oxidation Tretinoin [109], [110]
MR009636 Tretinoin 18-OH-RA Oxidation - Hydroxylation Tretinoin [109], [110], [111]
MR009629 Tretinoin 5,6-epoxy-RA Oxidation - Ring epoxidation Tretinoin [110], [110], [109]
MR009631 Tretinoin 13-cis RA Other reaction - Isomerization Tretinoin [111], [110]
MR002487 2-N-Propyl-4-oxopentanoic acid 2-Propylsuccinic acid Oxidation - 5-Hydroxylation Valproic acid [6]
MR002492 Valproic acid 4-hydroxyvalproic acid Oxidation - 4-Hydroxylation Valproic acid [6]
MR002494 Valproic acid 5-hydroxyvalproic acid Oxidation - 5-Hydroxylation Valproic acid [6]
MR002493 Valproic acid 4-ene-Valproic acid Oxidation - 3-Hydroxylation Valproic acid [6]
MR002495 Valproic acid 3-hydroxyvalproic acid Unclear - Unclear Valproic acid [6]
MR013079 Vonoprazan N-demethylated TAK-438 Oxidation - N-demethylation Vonoprazan [112], [113]
MR013080 Vonoprazan Vonoprazan M- Unclear - Unclear Vonoprazan [114], [113]
MR005674 Vortioxetine hydrobromide Vortioxetine Metabolite 4a Oxidation - Oxidationn Vortioxetine hydrobromide [26], [115]
MR006493 WY-1485 NLA-715 Oxidation - Hydrolyzationn WY-1485 [116], [7]
MR006497 Y-100032 Apli-dm Oxidation - C-dealkylation Y-100032 [60]
MR006071 Z-4828 L-ifosfamide Oxidation - Aliphatic hydroxylation Z-4828 [66]
⏷ Show the Full List of 89 MR(s)
Tissue/Disease-Specific Protein Abundances of This DME
      Tissue-specific Protein Abundances in Healthy Individuals Click to Show/Hide
      ICD Disease Classification 01 Infectious/parasitic disease Click to Show/Hide
                  ICD-11: 1C1H     Necrotising ulcerative gingivitis Click to Show/Hide
The Studied Tissue     Gingival tissue
The Specified Disease     Bacterial infection of gingival [ICD-11:1C1H]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.56E-01; Fold-change: -7.44E-03; Z-score: -2.07E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 1E30     Influenza Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Influenza [ICD-11:1E30]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.46E-03; Fold-change: 4.94E-01; Z-score: 4.13E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 1E51     Chronic viral hepatitis Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Chronic hepatitis C [ICD-11:1E51.1]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.33E-01; Fold-change: 4.58E-02; Z-score: 2.41E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 1G41     Sepsis with septic shock Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Sepsis with septic shock [ICD-11:1G41]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.62E-10; Fold-change: 1.45E-01; Z-score: 6.41E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: CA40     Respiratory syncytial virus infection Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Pediatric respiratory syncytial virus infection [ICD-11:CA40.11]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 6.79E-01; Fold-change: -2.31E-03; Z-score: -1.24E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: CA42     Rhinovirus infection Click to Show/Hide
The Studied Tissue     Nasal epithelium tissue
The Specified Disease     Rhinovirus infection [ICD-11:CA42.1]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.67E-01; Fold-change: -9.72E-02; Z-score: -1.52E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: KA60     Neonatal sepsis Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Neonatal sepsis [ICD-11:KA60]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.34E-02; Fold-change: -8.46E-02; Z-score: -3.27E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 02 Neoplasm Click to Show/Hide
                  ICD-11: 2A00     Brain cancer Click to Show/Hide
The Studied Tissue     Nervous tissue
The Specified Disease     Glioblastopma [ICD-11:2A00.00]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.89E-07; Fold-change: -8.67E-02; Z-score: -3.13E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Brain stem tissue
The Specified Disease     Glioma [ICD-11:2A00.0Y-2A00.0Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.06E-02; Fold-change: -1.34E-01; Z-score: -6.13E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     White matter tissue
The Specified Disease     Glioma [ICD-11:2A00.0Y-2A00.0Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.09E-08; Fold-change: -6.43E-01; Z-score: -3.81E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Brain stem tissue
The Specified Disease     Neuroectodermal tumour [ICD-11:2A00.11]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 8.90E-05; Fold-change: -1.12E+00; Z-score: -2.37E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2A20     Myeloproliferative neoplasm Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Myelofibrosis [ICD-11:2A20.2]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.75E-01; Fold-change: 1.41E-02; Z-score: 7.72E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Whole blood
The Specified Disease     Polycythemia vera [ICD-11:2A20.4]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.52E-03; Fold-change: 9.77E-02; Z-score: 5.23E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2A36     Myelodysplastic syndrome Click to Show/Hide
The Studied Tissue     Bone marrow
The Specified Disease     Myelodysplastic syndrome [ICD-11:2A36-2A3Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 5.55E-01; Fold-change: 9.45E-02; Z-score: 3.90E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 3.74E-02; Fold-change: -2.30E-01; Z-score: -1.83E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2A81     Diffuse large B-cell lymphoma Click to Show/Hide
The Studied Tissue     Tonsil tissue
The Specified Disease     Diffuse large B-cell lymphoma [ICD-11:2A81]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 9.39E-01; Fold-change: 3.69E-02; Z-score: 2.11E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2A83     Plasma cell neoplasm Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Multiple myeloma [ICD-11:2A83.1]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.88E-01; Fold-change: 7.42E-02; Z-score: 3.54E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Bone marrow
The Specified Disease     Multiple myeloma [ICD-11:2A83.1]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.57E-02; Fold-change: -2.75E-01; Z-score: -1.41E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2B33     Leukaemia Click to Show/Hide
The Studied Tissue     Bone marrow
The Specified Disease     Acute myelocytic leukaemia [ICD-11:2B33.1]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 5.37E-01; Fold-change: 2.12E-02; Z-score: 7.71E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2B6E     Oral cancer Click to Show/Hide
The Studied Tissue     Oral tissue
The Specified Disease     Oral cancer [ICD-11:2B6E]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.08E-03; Fold-change: -3.33E-01; Z-score: -1.10E+00
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 6.87E-01; Fold-change: -6.85E-02; Z-score: -1.91E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2B70     Esophageal cancer Click to Show/Hide
The Studied Tissue     Esophagus
The Specified Disease     Esophagal cancer [ICD-11:2B70]
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 2.04E-01; Fold-change: -7.17E-02; Z-score: -6.05E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2B72     Stomach cancer Click to Show/Hide
The Studied Tissue     Gastric tissue
The Specified Disease     Gastric cancer [ICD-11:2B72]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.33E-01; Fold-change: -1.87E-01; Z-score: -1.17E+00
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 1.74E-03; Fold-change: 1.70E-01; Z-score: 7.45E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2B90     Colon cancer Click to Show/Hide
The Studied Tissue     Colon tissue
The Specified Disease     Colon cancer [ICD-11:2B90]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.92E-04; Fold-change: -1.16E-01; Z-score: -4.54E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 7.13E-01; Fold-change: -3.72E-02; Z-score: -1.46E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2B92     Rectal cancer Click to Show/Hide
The Studied Tissue     Rectal colon tissue
The Specified Disease     Rectal cancer [ICD-11:2B92]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.73E-01; Fold-change: -8.05E-02; Z-score: -3.56E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 5.48E-01; Fold-change: 6.88E-04; Z-score: 2.59E-03
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C10     Pancreatic cancer Click to Show/Hide
The Studied Tissue     Pancreas
The Specified Disease     Pancreatic cancer [ICD-11:2C10]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 8.83E-01; Fold-change: -1.43E-01; Z-score: -4.14E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 6.93E-01; Fold-change: -2.00E-01; Z-score: -6.43E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C12     Liver cancer Click to Show/Hide
The Studied Tissue     Liver tissue
The Specified Disease     Liver cancer [ICD-11:2C12.0]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 5.71E-13; Fold-change: -4.22E+00; Z-score: -2.32E+00
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 4.51E-62; Fold-change: -3.15E+00; Z-score: -3.35E+00
The Expression Level of Disease Section Compare with the Other Disease Section     p-value: 8.38E-04; Fold-change: -4.34E+00; Z-score: -6.40E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
DME expression in tissue other than the diseased tissue of patients
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C25     Lung cancer Click to Show/Hide
The Studied Tissue     Lung tissue
The Specified Disease     Lung cancer [ICD-11:2C25]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 5.48E-01; Fold-change: -5.89E-02; Z-score: -1.77E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 3.90E-04; Fold-change: -1.99E-01; Z-score: -5.51E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C30     Skin cancer Click to Show/Hide
The Studied Tissue     Skin
The Specified Disease     Melanoma [ICD-11:2C30]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.24E-01; Fold-change: 1.08E-01; Z-score: 1.51E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Skin
The Specified Disease     Skin cancer [ICD-11:2C30-2C3Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.83E-08; Fold-change: -2.77E-01; Z-score: -5.15E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 1.59E-23; Fold-change: 9.47E-01; Z-score: 1.51E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C6Z     Breast cancer Click to Show/Hide
The Studied Tissue     Breast tissue
The Specified Disease     Breast cancer [ICD-11:2C60-2C6Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.15E-06; Fold-change: -4.25E-01; Z-score: -9.04E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 9.54E-01; Fold-change: -1.77E-01; Z-score: -4.40E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C73     Ovarian cancer Click to Show/Hide
The Studied Tissue     Ovarian tissue
The Specified Disease     Ovarian cancer [ICD-11:2C73]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 5.94E-01; Fold-change: -9.00E-02; Z-score: -4.71E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 9.81E-01; Fold-change: 4.97E-03; Z-score: 1.99E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C77     Cervical cancer Click to Show/Hide
The Studied Tissue     Cervical tissue
The Specified Disease     Cervical cancer [ICD-11:2C77]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.04E-03; Fold-change: -2.19E-01; Z-score: -9.35E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C78     Uterine cancer Click to Show/Hide
The Studied Tissue     Endometrium tissue
The Specified Disease     Uterine cancer [ICD-11:2C78]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.55E-04; Fold-change: -1.16E-01; Z-score: -4.21E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 3.51E-02; Fold-change: 2.06E-01; Z-score: 1.67E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C82     Prostate cancer Click to Show/Hide
The Studied Tissue     Prostate
The Specified Disease     Prostate cancer [ICD-11:2C82]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 8.39E-05; Fold-change: -1.04E+00; Z-score: -1.40E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C90     Renal cancer Click to Show/Hide
The Studied Tissue     Kidney
The Specified Disease     Renal cancer [ICD-11:2C90-2C91]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 9.77E-02; Fold-change: -2.66E-01; Z-score: -7.98E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 3.02E-14; Fold-change: -5.82E-01; Z-score: -1.62E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C92     Ureter cancer Click to Show/Hide
The Studied Tissue     Urothelium
The Specified Disease     Ureter cancer [ICD-11:2C92]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.47E-01; Fold-change: -5.85E-02; Z-score: -2.83E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2C94     Bladder cancer Click to Show/Hide
The Studied Tissue     Bladder tissue
The Specified Disease     Bladder cancer [ICD-11:2C94]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.75E-04; Fold-change: 5.92E-01; Z-score: 2.29E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2D02     Retinal cancer Click to Show/Hide
The Studied Tissue     Uvea
The Specified Disease     Retinoblastoma [ICD-11:2D02.2]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.27E-03; Fold-change: -3.92E-01; Z-score: -1.99E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2D10     Thyroid cancer Click to Show/Hide
The Studied Tissue     Thyroid
The Specified Disease     Thyroid cancer [ICD-11:2D10]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.50E-04; Fold-change: 1.16E-01; Z-score: 4.39E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 1.38E-01; Fold-change: 4.78E-03; Z-score: 1.45E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2D11     Adrenal cancer Click to Show/Hide
The Studied Tissue     Adrenal cortex
The Specified Disease     Adrenocortical carcinoma [ICD-11:2D11.Z]
The Expression Level of Disease Section Compare with the Other Disease Section     p-value: 5.44E-03; Fold-change: -1.10E-01; Z-score: -6.37E-01
DME expression in the diseased tissue of patients
DME expression in tissue other than the diseased tissue of patients
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2D12     Endocrine gland neoplasm Click to Show/Hide
The Studied Tissue     Pituitary tissue
The Specified Disease     Pituitary cancer [ICD-11:2D12]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.21E-01; Fold-change: 3.51E-01; Z-score: 8.33E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Pituitary tissue
The Specified Disease     Pituitary gonadotrope tumour [ICD-11:2D12]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.50E-02; Fold-change: 3.49E-01; Z-score: 1.14E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 2D42     Head and neck cancer Click to Show/Hide
The Studied Tissue     Head and neck tissue
The Specified Disease     Head and neck cancer [ICD-11:2D42]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.94E-13; Fold-change: -4.03E-01; Z-score: -6.01E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 03 Blood/blood-forming organ disease Click to Show/Hide
                  ICD-11: 3A51     Sickle cell disorder Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Sickle cell disease [ICD-11:3A51.0-3A51.3]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 9.21E-02; Fold-change: 2.41E-01; Z-score: 1.09E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 3A70     Aplastic anaemia Click to Show/Hide
The Studied Tissue     Bone marrow
The Specified Disease     Shwachman-Diamond syndrome [ICD-11:3A70.0]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.76E-01; Fold-change: 9.13E-02; Z-score: 4.54E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 3B63     Thrombocytosis Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Thrombocythemia [ICD-11:3B63]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.16E-02; Fold-change: 1.80E-01; Z-score: 9.50E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 3B64     Thrombocytopenia Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Thrombocytopenia [ICD-11:3B64]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.87E-01; Fold-change: 9.07E-02; Z-score: 2.80E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 04 Immune system disease Click to Show/Hide
                  ICD-11: 4A00     Immunodeficiency Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Immunodeficiency [ICD-11:4A00-4A20]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.07E-01; Fold-change: 5.60E-02; Z-score: 5.82E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 4A40     Lupus erythematosus Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Lupus erythematosus [ICD-11:4A40]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.10E-02; Fold-change: -3.16E-01; Z-score: -4.56E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 4A42     Systemic sclerosis Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Scleroderma [ICD-11:4A42.Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 8.08E-05; Fold-change: 1.77E-01; Z-score: 1.65E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 4A43     Systemic autoimmune disease Click to Show/Hide
The Studied Tissue     Salivary gland tissue
The Specified Disease     Sjogren's syndrome [ICD-11:4A43.2]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.61E-01; Fold-change: 1.05E-02; Z-score: 4.41E-02
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 3.20E-01; Fold-change: -8.21E-02; Z-score: -5.49E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 4A62     Behcet disease Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Behcet's disease [ICD-11:4A62]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.84E-01; Fold-change: 1.09E-01; Z-score: 5.16E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 4B04     Monocyte count disorder Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Autosomal dominant monocytopenia [ICD-11:4B04]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.66E-01; Fold-change: -7.53E-02; Z-score: -3.25E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 05 Endocrine/nutritional/metabolic disease Click to Show/Hide
                  ICD-11: 5A11     Type 2 diabetes mellitus Click to Show/Hide
The Studied Tissue     Omental adipose tissue
The Specified Disease     Obesity related type 2 diabetes [ICD-11:5A11]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.86E-01; Fold-change: 9.21E-02; Z-score: 6.54E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Liver tissue
The Specified Disease     Type 2 diabetes [ICD-11:5A11]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 6.97E-01; Fold-change: 2.69E-01; Z-score: 5.70E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 5A80     Ovarian dysfunction Click to Show/Hide
The Studied Tissue     Vastus lateralis muscle
The Specified Disease     Polycystic ovary syndrome [ICD-11:5A80.1]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.07E-01; Fold-change: -5.63E-02; Z-score: -3.55E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 5C51     Inborn carbohydrate metabolism disorder Click to Show/Hide
The Studied Tissue     Biceps muscle
The Specified Disease     Pompe disease [ICD-11:5C51.3]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.21E-02; Fold-change: -1.47E-01; Z-score: -1.06E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 5C56     Lysosomal disease Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Batten disease [ICD-11:5C56.1]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.40E-01; Fold-change: 1.05E-01; Z-score: 9.15E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 5C80     Hyperlipoproteinaemia Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Familial hypercholesterolemia [ICD-11:5C80.00]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 5.05E-01; Fold-change: -7.80E-02; Z-score: -3.56E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Whole blood
The Specified Disease     Familial hypercholesterolemia [ICD-11:5C80.00]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 8.16E-05; Fold-change: -5.46E-01; Z-score: -1.71E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 06 Mental/behavioural/neurodevelopmental disorder Click to Show/Hide
                  ICD-11: 6A02     Autism spectrum disorder Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Autism [ICD-11:6A02]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.98E-01; Fold-change: -2.30E-02; Z-score: -8.80E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 6A20     Schizophrenia Click to Show/Hide
The Studied Tissue     Prefrontal cortex
The Specified Disease     Schizophrenia [ICD-11:6A20]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 6.24E-01; Fold-change: 6.79E-02; Z-score: 2.28E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Superior temporal cortex
The Specified Disease     Schizophrenia [ICD-11:6A20]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.82E-01; Fold-change: -4.18E-02; Z-score: -2.80E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 6A60     Bipolar disorder Click to Show/Hide
The Studied Tissue     Prefrontal cortex
The Specified Disease     Bipolar disorder [ICD-11:6A60-6A6Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 5.78E-01; Fold-change: -6.08E-03; Z-score: -4.13E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 6A70     Depressive disorder Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Major depressive disorder [ICD-11:6A70-6A7Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.48E-01; Fold-change: -2.24E-02; Z-score: -7.80E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Hippocampus
The Specified Disease     Major depressive disorder [ICD-11:6A70-6A7Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.21E-02; Fold-change: 9.40E-02; Z-score: 6.62E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 08 Nervous system disease Click to Show/Hide
                  ICD-11: 8A00     Parkinsonism Click to Show/Hide
The Studied Tissue     Substantia nigra tissue
The Specified Disease     Parkinson's disease [ICD-11:8A00.0]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 8.99E-01; Fold-change: 4.59E-03; Z-score: 2.19E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8A01     Choreiform disorder Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Huntington's disease [ICD-11:8A01.10]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.51E-01; Fold-change: 5.05E-02; Z-score: 3.39E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8A20     Alzheimer disease Click to Show/Hide
The Studied Tissue     Entorhinal cortex
The Specified Disease     Alzheimer's disease [ICD-11:8A20]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.02E-01; Fold-change: -2.49E-02; Z-score: -1.81E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8A2Y     Neurocognitive impairment Click to Show/Hide
The Studied Tissue     White matter tissue
The Specified Disease     HIV-associated neurocognitive impairment [ICD-11:8A2Y-8A2Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.29E-02; Fold-change: -7.09E-02; Z-score: -3.37E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8A40     Multiple sclerosis Click to Show/Hide
The Studied Tissue     Plasmacytoid dendritic cells
The Specified Disease     Multiple sclerosis [ICD-11:8A40]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.56E-01; Fold-change: -6.70E-02; Z-score: -3.47E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Spinal cord
The Specified Disease     Multiple sclerosis [ICD-11:8A40]
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 1.41E-01; Fold-change: -2.43E-01; Z-score: -1.37E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8A60     Epilepsy Click to Show/Hide
The Studied Tissue     Peritumoral cortex tissue
The Specified Disease     Epilepsy [ICD-11:8A60-8A6Z]
The Expression Level of Disease Section Compare with the Other Disease Section     p-value: 4.75E-02; Fold-change: 2.15E-01; Z-score: 4.26E+00
DME expression in the diseased tissue of patients
DME expression in tissue other than the diseased tissue of patients
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Whole blood
The Specified Disease     Seizure [ICD-11:8A60-8A6Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 6.69E-02; Fold-change: -1.31E-01; Z-score: -7.17E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8B01     Subarachnoid haemorrhage Click to Show/Hide
The Studied Tissue     Intracranial artery
The Specified Disease     Intracranial aneurysm [ICD-11:8B01.0]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 5.49E-01; Fold-change: 2.01E-01; Z-score: 6.49E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8B11     Cerebral ischaemic stroke Click to Show/Hide
The Studied Tissue     Whole blood
The Specified Disease     Cardioembolic stroke [ICD-11:8B11.20]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.52E-07; Fold-change: 2.73E-01; Z-score: 1.88E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Peripheral blood
The Specified Disease     Ischemic stroke [ICD-11:8B11]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 5.94E-01; Fold-change: 2.54E-02; Z-score: 1.06E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8B60     Motor neuron disease Click to Show/Hide
The Studied Tissue     Skin
The Specified Disease     Lateral sclerosis [ICD-11:8B60.4]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.76E-01; Fold-change: 8.14E-02; Z-score: 9.84E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Cervical spinal cord
The Specified Disease     Lateral sclerosis [ICD-11:8B60.4]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 8.60E-01; Fold-change: 1.59E-02; Z-score: 5.91E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8C70     Muscular dystrophy Click to Show/Hide
The Studied Tissue     Muscle tissue
The Specified Disease     Myopathy [ICD-11:8C70.6]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.68E-01; Fold-change: -8.94E-02; Z-score: -3.91E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: 8C75     Distal myopathy Click to Show/Hide
The Studied Tissue     Muscle tissue
The Specified Disease     Tibial muscular dystrophy [ICD-11:8C75]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 8.92E-02; Fold-change: -6.11E-02; Z-score: -4.77E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 09 Visual system disease Click to Show/Hide
                  ICD-11: 9A96     Anterior uveitis Click to Show/Hide
The Studied Tissue     Peripheral monocyte
The Specified Disease     Autoimmune uveitis [ICD-11:9A96]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.48E-01; Fold-change: -1.59E-02; Z-score: -1.03E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 11 Circulatory system disease Click to Show/Hide
                  ICD-11: BA41     Myocardial infarction Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Myocardial infarction [ICD-11:BA41-BA50]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.53E-02; Fold-change: 1.64E-01; Z-score: 2.20E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: BA80     Coronary artery disease Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Coronary artery disease [ICD-11:BA80-BA8Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.54E-01; Fold-change: 2.14E-02; Z-score: 8.50E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: BB70     Aortic valve stenosis Click to Show/Hide
The Studied Tissue     Calcified aortic valve
The Specified Disease     Aortic stenosis [ICD-11:BB70]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 9.73E-01; Fold-change: 2.55E-02; Z-score: 3.48E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 12 Respiratory system disease Click to Show/Hide
                  ICD-11: 7A40     Central sleep apnoea Click to Show/Hide
The Studied Tissue     Hyperplastic tonsil
The Specified Disease     Apnea [ICD-11:7A40]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.22E-02; Fold-change: -2.39E-01; Z-score: -1.22E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: CA08     Vasomotor or allergic rhinitis Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Olive pollen allergy [ICD-11:CA08.00]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.87E-02; Fold-change: 2.08E-01; Z-score: 1.53E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: CA0A     Chronic rhinosinusitis Click to Show/Hide
The Studied Tissue     Sinus mucosa tissue
The Specified Disease     Chronic rhinosinusitis [ICD-11:CA0A]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.90E-02; Fold-change: -5.08E-01; Z-score: -1.19E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: CA22     Chronic obstructive pulmonary disease Click to Show/Hide
The Studied Tissue     Lung tissue
The Specified Disease     Chronic obstructive pulmonary disease [ICD-11:CA22]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.70E-01; Fold-change: 2.63E-01; Z-score: 6.12E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Small airway epithelium
The Specified Disease     Chronic obstructive pulmonary disease [ICD-11:CA22]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.35E-03; Fold-change: -2.46E-01; Z-score: -5.85E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: CA23     Asthma Click to Show/Hide
The Studied Tissue     Nasal and bronchial airway
The Specified Disease     Asthma [ICD-11:CA23]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.41E-01; Fold-change: 3.13E-01; Z-score: 2.71E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: CB03     Idiopathic interstitial pneumonitis Click to Show/Hide
The Studied Tissue     Lung tissue
The Specified Disease     Idiopathic pulmonary fibrosis [ICD-11:CB03.4]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.23E-01; Fold-change: 2.71E-01; Z-score: 8.39E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 13 Digestive system disease Click to Show/Hide
                  ICD-11: DA0C     Periodontal disease Click to Show/Hide
The Studied Tissue     Gingival tissue
The Specified Disease     Periodontal disease [ICD-11:DA0C]
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 4.45E-03; Fold-change: 9.41E-02; Z-score: 2.61E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: DA42     Gastritis Click to Show/Hide
The Studied Tissue     Gastric antrum tissue
The Specified Disease     Eosinophilic gastritis [ICD-11:DA42.2]
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 9.54E-01; Fold-change: -1.49E-02; Z-score: -6.55E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: DB92     Non-alcoholic fatty liver disease Click to Show/Hide
The Studied Tissue     Liver tissue
The Specified Disease     Non-alcoholic fatty liver disease [ICD-11:DB92]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.76E-01; Fold-change: -3.41E-01; Z-score: -6.74E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: DB99     Hepatic failure Click to Show/Hide
The Studied Tissue     Liver tissue
The Specified Disease     Liver failure [ICD-11:DB99.7-DB99.8]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.37E-02; Fold-change: -1.33E+00; Z-score: -1.11E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: DD71     Ulcerative colitis Click to Show/Hide
The Studied Tissue     Colon mucosal tissue
The Specified Disease     Ulcerative colitis [ICD-11:DD71]
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 7.77E-01; Fold-change: 6.19E-02; Z-score: 2.01E-01
DME expression in the diseased tissue of patients
DME expression in tissue other than the diseased tissue of patients
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: DD91     Irritable bowel syndrome Click to Show/Hide
The Studied Tissue     Rectal colon tissue
The Specified Disease     Irritable bowel syndrome [ICD-11:DD91.0]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 4.31E-01; Fold-change: 2.64E-02; Z-score: 1.27E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 14 Skin disease Click to Show/Hide
                  ICD-11: EA80     Atopic eczema Click to Show/Hide
The Studied Tissue     Skin
The Specified Disease     Atopic dermatitis [ICD-11:EA80]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.48E-01; Fold-change: 8.29E-02; Z-score: 9.03E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: EA90     Psoriasis Click to Show/Hide
The Studied Tissue     Skin
The Specified Disease     Psoriasis [ICD-11:EA90]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.19E-13; Fold-change: -3.40E-01; Z-score: -7.68E-01
The Expression Level of Disease Section Compare with the Adjacent Tissue     p-value: 9.69E-48; Fold-change: 1.12E+00; Z-score: 4.84E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue adjacent to the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: ED63     Acquired hypomelanotic disorder Click to Show/Hide
The Studied Tissue     Skin
The Specified Disease     Vitiligo [ICD-11:ED63.0]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 6.56E-01; Fold-change: -1.48E-02; Z-score: -1.10E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: ED70     Alopecia or hair loss Click to Show/Hide
The Studied Tissue     Skin from scalp
The Specified Disease     Alopecia [ICD-11:ED70]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 3.91E-01; Fold-change: 1.03E-01; Z-score: 3.69E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: EK0Z     Contact dermatitis Click to Show/Hide
The Studied Tissue     Skin
The Specified Disease     Sensitive skin [ICD-11:EK0Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.41E-01; Fold-change: 1.65E-02; Z-score: 8.11E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 15 Musculoskeletal system/connective tissue disease Click to Show/Hide
                  ICD-11: FA00     Osteoarthritis Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Arthropathy [ICD-11:FA00-FA5Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 6.07E-01; Fold-change: -1.87E-02; Z-score: -1.29E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Synovial tissue
The Specified Disease     Osteoarthritis [ICD-11:FA00-FA0Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 6.41E-01; Fold-change: 1.23E-02; Z-score: 5.46E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: FA20     Rheumatoid arthritis Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Childhood onset rheumatic disease [ICD-11:FA20.Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 6.22E-01; Fold-change: 1.37E-01; Z-score: 3.71E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
The Studied Tissue     Synovial tissue
The Specified Disease     Rheumatoid arthritis [ICD-11:FA20]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.32E-02; Fold-change: -5.21E-01; Z-score: -1.72E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: FA24     Juvenile idiopathic arthritis Click to Show/Hide
The Studied Tissue     Peripheral blood
The Specified Disease     Juvenile idiopathic arthritis [ICD-11:FA24]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 9.70E-03; Fold-change: 6.62E-03; Z-score: 3.43E-02
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: FA92     Inflammatory spondyloarthritis Click to Show/Hide
The Studied Tissue     Pheripheral blood
The Specified Disease     Ankylosing spondylitis [ICD-11:FA92.0Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 9.39E-01; Fold-change: 4.37E-02; Z-score: 3.39E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: FB83     Low bone mass disorder Click to Show/Hide
The Studied Tissue     Bone marrow
The Specified Disease     Osteoporosis [ICD-11:FB83.1]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.47E-03; Fold-change: 3.88E-01; Z-score: 3.09E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 16 Genitourinary system disease Click to Show/Hide
                  ICD-11: GA10     Endometriosis Click to Show/Hide
The Studied Tissue     Endometrium tissue
The Specified Disease     Endometriosis [ICD-11:GA10]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 1.99E-02; Fold-change: 1.17E-01; Z-score: 5.72E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: GC00     Cystitis Click to Show/Hide
The Studied Tissue     Bladder tissue
The Specified Disease     Interstitial cystitis [ICD-11:GC00.3]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 2.24E-01; Fold-change: 1.21E-01; Z-score: 8.15E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 19 Condition originating in perinatal period Click to Show/Hide
                  ICD-11: KA21     Short gestation disorder Click to Show/Hide
The Studied Tissue     Myometrium
The Specified Disease     Preterm birth [ICD-11:KA21.4Z]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 9.54E-01; Fold-change: 2.76E-02; Z-score: 3.03E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
      ICD Disease Classification 20 Developmental anomaly Click to Show/Hide
                  ICD-11: LD2C     Overgrowth syndrome Click to Show/Hide
The Studied Tissue     Adipose tissue
The Specified Disease     Simpson golabi behmel syndrome [ICD-11:LD2C]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 9.63E-01; Fold-change: -5.44E-02; Z-score: -5.89E-01
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
                  ICD-11: LD2D     Phakomatoses/hamartoneoplastic syndrome Click to Show/Hide
The Studied Tissue     Perituberal tissue
The Specified Disease     Tuberous sclerosis complex [ICD-11:LD2D.2]
The Expression Level of Disease Section Compare with the Healthy Individual Tissue     p-value: 7.54E-02; Fold-change: 1.22E-01; Z-score: 1.17E+00
DME expression in the diseased tissue of patients
DME expression in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Protein Abundances Click to View the Clearer Original Diagram
References
1 Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients. J Biochem Mol Toxicol. 2000;14(3):140-7.
2 Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis. 1994 Jan;15(1):5-9.
3 CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine delta-5'(1')iminium ion. J Pharmacol Exp Ther. 2012 Nov;343(2):307-15.
4 Apremilast (Otezla): a new oral treatment for adults with psoriasis and psoriatic arthritis. P T. 2015 Aug;40(8):495-500.
5 Health control over the feeding of troops on the Western and 3d Belorussian Fronts during the Great Patriotic War years. Voen Med Zh. 1975 Jun;(6):86-8.
6 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
7 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
8 The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst. Drug Metab Dispos. 2013 Sep;41(9):1686-94.
9 Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamide. J Cancer Res Clin Oncol. 2002 Jul;128(7):385-92.
10 Psychotropic drug interactions with valproate. Clin Neuropharmacol. 2005 Mar-Apr;28(2):96-101.
11 Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Anesthesiology. 2001 Aug;95(2):509-14.
12 Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions. Br J Pharmacol. 2000 Apr;129(8):1655-67.
13 Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist. Drug Metab Dispos. 2012 Apr;40(4):761-71.
14 Drug Interactions Flockhart Table
15 Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignancies
16 FDA label of Cenobamate. The 2020 official website of the U.S. Food and Drug Administration.
17 Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab Dispos. 1999 Jun;27(6):655-66.
18 Impact of CYP2A6 gene polymorphism on the pharmacokinetics of dexmedetomidine for premedication. Expert Rev Clin Pharmacol. 2018 Sep;11(9):917-922.
19 Biotransformation of Efavirenz and Proteomic Analysis of Cytochrome P450s and UDP-Glucuronosyltransferases in Mouse, Macaque, and Human Brain-Derived In Vitro Systems. Drug Metab Dispos. 2023 Apr;51(4):521-531. doi: 10.1124/dmd.122.001195.
20 Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator? Drug Metab Dispos. 2009 Jan;37(1):10-3.
21 Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs. Drug Metab Dispos. 1999 Dec;27(12):1381-91.
22 Characterization of human cytochrome P450s involved in the bioactivation of clozapine. Drug Metab Dispos. 2013 Mar;41(3):651-8.
23 Evidence for the involvement of N-methylthiourea, a ring cleavage metabolite, in the hepatotoxicity of methimazole in glutathione-depleted mice: structure-toxicity and metabolic studies
24 Role of CYP2A6 in Methimazole Bioactivation and Hepatotoxicity
25 Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth. 1998 Jun;80(6):788-95.
26 Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004. Drug Metab Dispos. 2012 Jul;40(7):1357-65.
27 Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies. J Pharm Pharmacol. 2017 Dec;69(12):1762-1772.
28 Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2. Clin Pharmacokinet. 2014 Jan;53(1):17-27.
29 Metabolic activation of deferiprone mediated by CYP2A6 Xenobiotica. 2021 Nov;51(11):1282-1291. doi: 10.1080/00498254.2021.1931729.
30 Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab Dispos. 2000 Dec;28(12):1457-63.
31 The impact of individual human cytochrome P450 enzymes on oxidative metabolism of anticancer drug lenvatinib
32 N-demethylation of levo-alpha-acetylmethadol by human placental aromatase. Biochem Pharmacol. 2004 Mar 1;67(5):885-92.
33 Timolol metabolism in human liver microsomes is mediated principally by CYP2D6. Drug Metab Dispos. 2007 Jul;35(7):1135-41.
34 A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes. Drug Metab Dispos. 2007 Oct;35(10):1797-805.
35 Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450
36 Lithium Intoxication in the Elderly: A Possible Interaction between Azilsartan, Fluvoxamine, and Lithium
37 Oxidative metabolism of flunarizine and cinnarizine by microsomes from B-lymphoblastoid cell lines expressing human cytochrome P450 enzymes. Biol Pharm Bull. 1996 Nov;19(11):1511-4.
38 Moxidectin and the avermectins: Consanguinity but not identity
39 Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special Populations
40 Variation in CYP2A6 activity and personalized medicine. J Pers Med. 2017 Dec 1;7(4). pii: E18.
41 High prevalence of CYP2A6*4 and CYP2A6*9 alleles detected among a Malaysian population
42 Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Drug Metab Dispos. 1999 Nov;27(11):1274-80.
43 Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension
44 In vitro metabolism of dorzolamide, a novel potent carbonic anhydrase inhibitor, in rat liver microsomes. Drug Metab Dispos. 1994 Nov-Dec;22(6):916-21.
45 Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer. Breast Cancer Res Treat. 2018 Nov;172(2):371-379.
46 Metabolism of Meloxicam in human liver involves cytochromes P4502C9 and 3A4. Xenobiotica. 1998 Jan;28(1):1-13.
47 Metabolism of (+)- and (-)-menthols by CYP2A6 in human liver microsomes
48 Involvement of CYP2A6 in the formation of a novel metabolite, 3-hydroxypilocarpine, from pilocarpine in human liver microsomes
49 Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology. 1995 Mar;82(3):689-99.
50 Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Curr Drug Metab. 2009 Sep;10(7):754-80.
51 CYP2A6: a human coumarin 7-hydroxylase
52 Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br J Clin Pharmacol. 1999 Oct;48(4):528-35.
53 UFT Capsules (uracil-tegafur).
54 Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes. Xenobiotica. 1999 Sep;29(9):885-98.
55 CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. Drug Metab Dispos. 2001 Feb;29(2):133-40.
56 The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. Eur Neuropsychopharmacol. 2004 May;14(3):199-208.
57 Rapid development of S-1 in the west for therapy of advanced gastric carcinoma. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:117-20.
58 Metabolism, Excretion, and Pharmacokinetics of Selumetinib, an MEK1/2 inhibitor, in Healthy Adult Male Subjects
59 Australian Public Assessment Report for asunaprevir.
60 In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug. Invest New Drugs. 2007 Feb;25(1):9-19.
61 Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity. PLoS One. 2013 Sep 23;8(9):e75494.
62 Disposition and metabolism of semagacestat, a {gamma}-secretase inhibitor, in humans. Drug Metab Dispos. 2010 Apr;38(4):554-65.
63 In vitro metabolism of (-)-camphor using human liver microsomes and CYP2A6. Biol Pharm Bull. 2007 Feb;30(2):230-3.
64 In vitro characterization of sarizotan metabolism: hepatic clearance, identification and characterization of metabolites, drug-metabolizing enzyme identification, and evaluation of cytochrome p450 inhibition. Drug Metab Dispos. 2010 Jun;38(6):905-16.
65 Cytochrome P450 enzymes involved in the metabolic pathway of the histamine 2 (H2)-receptor antagonist roxatidine acetate by human liver microsomes. Arzneimittelforschung. 2001;51(8):651-8.
66 Metabolism and transport of oxazaphosphorines and the clinical implications Drug Metab Rev. 2005;37(4):611-703. doi: 10.1080/03602530500364023.
67 Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol. 2003 Sep;59(5-6):429-42.
68 In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomes
69 Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug
70 A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502)
71 Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation
72 Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation
73 Site-specific oxidation of flavanone and flavone by cytochrome P450 2A6 in human liver microsomes. Xenobiotica. 2019 Jul;49(7):791-802.
74 Urinary metabolites of dibutyl phthalate and benzophenone-3 are potential chemical risk factors of chronic kidney function markers among healthy women
75 Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation
76 Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. Drug Metab Dispos. 1996 Apr;24(4):487-94.
77 The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol Appl Pharmacol. 2008 Dec 1;233(2):343-52.
78 Roles of human CYP2A6 and 2B6 and rat CYP2C11 and 2B1 in the 10-hydroxylation of (-)-verbenone by liver microsomes. Drug Metab Dispos. 2003 Aug;31(8):1049-53.
79 Stability of the nicotine metabolite ratio in ad libitum and reducing smokers. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1396-400.
80 Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents FASEB J. 2010 Dec;24(12):4904-16. doi: 10.1096/fj.10-162438.
81 Rapid detection and quantification of paracetamol and its major metabolites using surface enhanced Raman scattering. Analyst. 2023 Apr 11;148(8):1805-1814. doi: 10.1039/d3an00249g.
82 Disposition, metabolism and mass balance of [(14)C]apremilast following oral administration. Xenobiotica. 2011 Dec;41(12):1063-75.
83 A cytochrome P450 class I electron transfer system from Novosphingobium aromaticivorans. Appl Microbiol Biotechnol. 2010 Mar;86(1):163-75.
84 DrugBank(Pharmacology-Metabolism)BRN-1907611
85 DrugBank : Cinnarizine
86 Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice. Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):403-12.
87 In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II inhibitor, in animals and humans Drug Metab Dispos. 2010 Mar;38(3):405-14. doi: 10.1124/dmd.109.029165.
88 Analytical method development for the simultaneous quantitation of dexmedetomidine and three potential metabolites in plasma J Chromatogr A. 1997 Feb 21;762(1-2):281-91. doi: 10.1016/s0021-9673(96)00965-x.
89 Mass balance and metabolism of [(3)H]Formoterol in healthy men after combined i.v. and oral administration-mimicking inhalation Drug Metab Dispos. 1999 Oct;27(10):1104-16.
90 FDA Approved Drug Products: Perforomist? inhalation solution
91 Cytochromes P450: a structure-based summary of biotransformations using representative substrates Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742.
92 The KEGG resource for deciphering the genome
93 Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4'-methanol-bisbenzonitrile in vitro. Cancer Chemother Pharmacol. 2009 Oct;64(5):867-75.
94 A prospective longitudinal study of growth in twin gestations compared with growth in singleton pregnancies. I. The fetal head J Ultrasound Med. 1991 Aug;10(8):439-43. doi: 10.7863/jum.1991.10.8.439.
95 Disposition and metabolism of metronidazole in patients with liver failure
96 Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation
97 Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms
98 In vitro metabolism of montelukast by cytochrome P450s and UDP-glucuronosyltransferases. Drug Metab Dispos. 2015 Dec;43(12):1905-16.
99 NORMAN Suspect List Exchange:Levomenthol
100 Pharmacogenomics knowledge for personalized medicine Clin Pharmacol Ther. 2012 Oct;92(4):414-7. doi: 10.1038/clpt.2012.96.
101 U. S. FDA Label -Nicotine
102 Oxidative bioactivation of nitrofurantoin in rat liver microsomes Xenobiotica. 2017 Feb;47(2):103-111. doi: 10.3109/00498254.2016.1164913.
103 DrugBank(Pharmacology-Metabolism)Phenacetin
104 (+)-cis-3,5-dimethyl-2-(3-pyridyl) thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes
105 S-oxidation of (+)-cis-3,5-dimethyl-2-(3-pyridyl)-thiazolidin-4-one hydrochloride by rat hepatic flavin-containing monooxygenase 1 expressed in yeast
106 In vitro metabolism of irosustat, a novel steroid sulfatase inhibitor: interspecies comparison, metabolite identification, and metabolic enzyme identification
107 DrugBank(Pharmacology-Metabolism):Tegafur-uracil
108 Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation
109 Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol. 2000 Dec;58(6):1341-8.
110 Retinoic acid metabolism and mechanism of action: a review
111 Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids
112 Assessments of CYP?inhibition?based drug-drug interaction between vonoprazan and poziotinib in?vitro and in?vivo
113 In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker. Xenobiotica. 2017 Dec;47(12):1027-1034.
114 Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date
115 Vortioxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2018 Jun;57(6):673-686.
116 BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.